Neuromuscular disorders in the newborn

Clinics in Perinatology

Volumn 24, Issue 4, 1997, Pages 827-844

  Darras, B T ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; CARNITINE PALMITOYLTRANSFERASE; CYTOCHROME C OXIDASE; EDROPHONIUM CHLORIDE; GLUCAN 1,4 ALPHA GLUCOSIDASE; MAGNESIUM SULFATE; NEOSTIGMINE METHYL SULFATE; PHOSPHORYLASE;

ARTHROGRYPOSIS; BOTULISM; ENZYME DEFICIENCY; GUILLAIN BARRE SYNDROME; HUMAN; INBORN ERROR OF METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE BIOPSY; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYASTHENIA GRAVIS; MYOPATHY; NERVE BIOPSY; NEUROMUSCULAR DISEASE; NEUROPATHY; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; REVIEW; SPINAL MUSCULAR ATROPHY; SUBCUTANEOUS DRUG ADMINISTRATION; WALKER WARBURG SYNDROME; WERDNIG HOFFMANN DISEASE;

EID: 0030658908     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0095-5108(18)30152-0     Document Type: Review

References (63)

1. Aslanidis C. Jansen G. Amemiya C. Cloning of the essential myotonic dystrophy region and mapping of the putative defect Nature 355 1992 548 551
2. Bresolin N. Zeviani M. Bonilla E. Molecular defects in cytochrome c oxidase deficiency: Decrease of immunologically detectable enzyme in muscle Neurology 35 1985 802
3. Brook J.D. McCurrach M. Harley A. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat located at the 3’ end of a transcript encoding a protein kinase family member Cell 68 1992 799
4. Brooke M.H. Congenital fiber type disproportion Kakulas B.A. Clinical Studies in Myology 1973 Excerpta Medica Inc Amsterdam 147
5. Brunner H.G. Nillesen W. van Oost B.A. Presymptomatic diagnosis of myotonic dystrophy J Med Genet 29 1992 780 784
6. Bulkley B.H. Hutchins G.M. Pompe’s disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome Am Heart J 92 1978 246 252
7. Bundey S. Spinal muscular atrophies (SMAs) Bundey S. Genetics and Neurology 1985 Churchill Livingstone Edinburgh 172
8. Byers R.K. Banker B.Q. Infantile muscular atrophy Arch Neurol 5 1961 140 164
9. Byrne E. Blumbergs P.C. Hallpike J.F. Central core disease: Study of a family with five affected generations J Neurol Sei 53 1982 77
10. Cherington M. Botulism: Clinical, electrical and therapeutic considerations Lewis G.E. Biomedical Aspects of Botulism 1981 Academic New York 327 330
11. Cornblath D.R. Sladky J.T. Sumner A.J. Clinical electrophysiology of infantile botulism Muse Nerv 6 1983 448 452
12. Denborough M.A. Dennett X.K. Anderson R.M. Central core disease and malignant hyperthermia Br Med J 1 1973 272
13. DiMauro S. Hartlage P. Fatal infantile form of muscle phosphorylase deficiency Neurology 28 1978 1124
14. Dobyns W.B. Pagon R.A. Armstrong D. Diagnostic criteria for Walker-Warburg syndrome Am J Med Genet 32 1989 195 210
15. Dobyns W.B. Truwit C.L. Lissencephaly and other malformations of cortical development: 1995 update Neuropediatrics 26 1995 132 147
16. Dubowitz V. 41st ENMC international workshop on congenital muscular dystrophy Neuromusc Disord 6 1996 295 306
17. Dubowitz V. Disorders of the lower motor neurone: The spinal muscular atrophies Dubowitz V. Muscle Disorders in Childhood 1995 Saunders Philadelphia 325 369
18. Engel W.K. Foster J.B. Hughes B.P. Central core disease-An investigation of a rare muscle cell abnormality Brain 84 1961 167
19. Fukuyama Y. Osawa M. Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type: Clinical, genetic and pathological considerations Brain Dev 3 1981 1 29
20. Gilliam T.C. Brzustowicz L.M. The molecular basis of the spinal muscular atrophies Rosenberg R.N. Pruisner S.B. DiMauro S. The Molecular and Genetic Basis of Neurological Disease 1993 Butterworth-Heinemann Stoneham, MA 883 887
21. Gutman L. Pratt L. Pathophysiologic aspects of human botulism Arch Neurol 33 1976 175 179
22. Haan E.A. Freemantle C.J. McCure J. Assignment of the gene for central core disease to chromosome 19 Hum Genet 86 1990 187
23. Hahnen E. Forkert R. Marke C. Molecular analysis of candidate genes on 5ql3 in autosomal recessive spinal muscular atrophy: Evidence of homozygous deletions of the SMN gene in unaffected individuals Hum Mol Genet 4 1995 1927 1933
24. Haltia M. Leivo I. Some rH. Muscle-eye-brain disease: A neuropathological study Ann Neurol 41 1997 173 180
25. Harley H.G. Rundle S.A. Reardon W. Unstable DNA sequence in myotonic dystrophy Lancet 339 1992 1125 1128
26. Harper C.M. Neuromuscular transmission disorders in childhood Jones R.H. Bolton C.F. Harper C.M. Pediatric Clinical Electromyography 1996 Lippincott-Raven Philadelphia 353 385
27. Helbling-Leclerc A. Zhang X. Topaloglu H. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy Nat Genet 11 1995 216 218
28. Ishibashi-Ueda H. Imakita N. Yutani C. Congenital nemaline myopathy with dilated cardiomyopathy: An autopsy study Hum Pathol 21 1990 77
29. Kinney R.B. Gottfried M.R. Hodson A.K. Congenital giant axonal neuropathy Arch Pathol Lab Med 109 1985 639 641
30. Kinoshita M. Cadman T.E. Myotubular myopathy Arch Neurol 18 1968 265
31. Kobayashi O. Hayashi Y. Arahata K. Congenital muscular dystrophy: Clinical and pathologic study of 50 patients with the classical (occidental) merosin-positive form Neurology 46 1996 815 818
32. Laing N.G. Majda B.T. Akkari P. Assignment of a gene (NEM) for autosomal dominant nemaline myopathy to chromosome 1 Am J Hum Genet 50 1992 576
33. Laing N.G. Wilton S.D. Akkari P.A. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy Nat Genet 9 1995 75 79
34. Laporte J. Hu L.J. Kretz C. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast Nat Genet 13 1996 175 182
35. Lefebvre S. Burglen L. Reboullet S. Identification and characterization of a spinal muscular atrophy-determining gene Cell 80 1995 155 165
36. Lenard H.G. Goebel H.H. Congenital fibre type disproportion Neuropediatrics 6 1975 220
37. Milstein J.M. Herron T.M. Haas J.E. Fatal infantile phosphorylase deficiency J Child Neurol 4 1989 186
38. Morrison K.E. Harding A.E. Disorders of the motor neuron Harding A.E. Genetics Neurology 1994 Bailliere Tindall London 431 445
39. Munsat T.L. Workshop report: International SMA collaboration Neuromusc Disord 1 1991 81
40. Norton A. Ellison P. Sulaiman A.R. Nemaline myopathy in the neonate Neurology 33 1983 351
41. Philpot J. Sewry C. Pennock J. Clinical phenotype in congenital muscular dystrophy: Correlation with expression of merosin in skeletal muscle Neuromusc Disord 5 1995 301 305
42. Rimoldi M. Bottacchi E. Rossi L. Cytochrome-c-oxidase deficiency in muscle of a floppy infant without mitochondrial myopathy J Neurol 227 1982 201
43. Roy N. Mahadevan M.S. McLean M. The gene for neuronal apoptosis inhibitor protein (NAIP), a novel protein with homology to baculoviral inhibitors of apoptosis is partially deleted in individuals with type I, II, and III spinal muscular atrophy (SMA) Cell 80 1995 167 178
44. Salafsky I.S. Nadler H.L. Deficiency of acid alpha glucosidase in the urine of patients with Pompe disease J Pediatr 82 1973 294 298
45. Santavuori P. Somer H. Sainio K. Muscle-eye brain disease (MEB) Brain Dev 11 1989 147 153
46. Scarlato G. Pellegrini G. Moggio M. Familial nemaline myopathy Neuropediatrics 13 1982 211
47. Servidei S. Bonilla E. Diedrich R.G. Fatal infantile form of muscle phosphofructokinase deficiency Neurology 36 1986 1465
48. Shafig S.A. Dubowitz V. Peterson H. Nemaline myopathy: Report of a fatal case with histochemical and electron microscopic studies Brain 90 1967 817
49. Shorer Z. Philpot J. Muntoni F. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy J Child Neurol 10 1995 472 475
50. Shy G.M. Engel W.K. Somers J.E. Nemaline myopathy: A new congenital myopathy Brain 86 1963 793
51. Shy G.M. Magee K.R. A new congenital non-progressive myopathy Brain 79 1956 610
52. Sladky JT: Chronic sensory-motor neuropathies in children. Annual Meeting of the American Association of Electrodiagnostic Medicine: Course A. New Orleans, 1993
53. Spiro A.J. Shy G.M. Gonatas N.K. Myotubular myopathy: Persistence of fetal muscle in an adolescent boy Arch Neurol 14 1966 1
54. Suthers G.K. Huson S.M. Davies K.E. Instability versus predictability: The molecular diagnosis of myotonic dystrophy J Med Genet 29 1992 761 765
55. Thomas N.S.T. Sarfarazi M. Roberts K. X-linked myotubular myopathy (MTM1) evidence for linkage to Xq28 DNA marker loci J Med Genet 27 1990 284 287
56. Toda T. Segawa M. Normura Y. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31–33 Nat Genet 5 1993 283 286
57. Tome F.M. Evangelista T. Leclerc A. Congenital muscular dystrophy with merosin deficiency CR Acad Sei III 317 1994 251 357
58. Tritschier H.J. Bonilla E. Lombes A. Differential diagnoses of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: An immunohistochemical approach Neurology 41 1991 300
59. Wallgren-Pettersson C. Arjomaa P. Holmberg C. Alpha-actinin and myosin light chains in congenital nemaline myopathy Pediatr Neurol 6 1990 171 174
60. Yoshioka M. Kuroki S. Clinical spectrum and genetic studies of Fukuyama congenital muscular dystrophy Am J Med Genet 53 1994 245 250
61. Zeviani M. Peterson P. Servidei S. Benign reversible muscle cytochrome c oxidase deficiency: A second case Neurology 37 1987 64
62. Zhang Y. Chen H.S. Khanna V.K. A mutation in the human ryanodine receptor gene associated with central core disease Nat Genet 5 1993 46
63. Zhong N. Martiniuk F. Tzall S. Identification of a missense mutation in one allele of a patient with Pompe disease, and use of endonuclease digestion of PCR-amplified RNA to demonstrate lack of mRNA expression from the second allele Am J Hum Genet 49 1991 635 645